Business Context and Reporting Period
This Form 6-K filing by Braskem S.A. reports on the minutes of an Extraordinary General Meeting held on November 13, 2025. The filing does not contain financial results for a specific reporting period but documents corporate governance actions, including Board of Director changes and amendments to the Company's Bylaws.
Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on shareholder resolutions and corporate governance updates.
Material Changes and Corporate Actions
- Board of Directors Replacement: Shareholders approved the election of Mr. Lucas Cive Barbosa to replace Mr. Roberto Faldini as an effective member of the Board of Directors. This appointment was indicated by major shareholders Novonor S.A. and NSP Investimentos S.A. The term concludes at the Annual General Meeting resolving the 2025 fiscal year statements.
- Bylaws Amendment (Corporate Purpose): Article 2 of the Bylaws was amended to align the corporate purpose with current activities, explicitly including the manufacture and trade of products from biotechnology, renewable sources, and recycled products, as well as electricity trading and digital technologies.
- Board Election Procedures: A new Article 20 was added to mandate a slate system for Board elections, prohibiting individual voting for candidates (with specific exceptions). This aims to increase transparency and structure in the election process.
- Board Authority and Thresholds: Article 26 was amended to:
- Update Board approval thresholds for investments and asset acquisitions (e.g., operational investments over R$240 million; asset acquisitions over R$480 million).
- Authorize the Board to annually adjust these thresholds based on inflation (IPCA).
- Remove the responsibility of selecting and replacing independent auditors for subsidiaries from the Board, transferring this authority to the Executive Board.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer regarding forward-looking statements. It notes that actual results may differ due to risks including:
- General economic and market conditions.
- Industry conditions and operating factors.
- Specific references to the potential impact of a geological event in Alagoas and related legal proceedings.
- References to the impact of the COVID-19 pandemic (noted in the standard disclaimer text).
No specific financial guidance or management commentary on future performance was provided in this document.
Key Facts for Investor Verification
- Shareholder Approval: All agenda items were approved with overwhelming support, with approximately 97.9% of common shares and 52.4% to 57.1% of preferred shares voting in favor.
- Major Shareholder Influence: The replacement of the Board member was driven by Novonor S.A. and NSP Investimentos S.A., both noted as being under Judicial Reorganization.
- Governance Shift: The new slate voting system and the transfer of subsidiary auditor selection to the Executive Board represent significant changes to the Company's internal control and governance structure.
- Strategic Focus: The updated corporate purpose explicitly highlights renewable sources, biotechnology, and circular economy products, signaling a strategic pivot or emphasis in these areas.